CJC-1295 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
CJC-1295 is one of the most discussed peptides in the research community, with reports focusing on its effects on increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects. Clinical research demonstrates significant increases in GH and IGF-1 levels in human subjects. Studies show improved body composition with increased lean mass and reduced body fat, particularly when combined with GHRP peptides like Ipamorelin.
What Do Researchers Report About CJC-1295?
CJC-1295 (CJC-1295 (Modified GRF 1-29)) is one of the most discussed Growth Hormone Releasing Hormone (GHRH) analog compounds in the peptide research community. Reports span effects on increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects.
Clinical research demonstrates significant increases in GH and IGF-1 levels in human subjects. Studies show improved body composition with increased lean mass and reduced body fat, particularly when combined with GHRP peptides like Ipamorelin.
What Are the Most Common Positive Reports?
Researchers frequently cite CJC-1295's effects on increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects as the primary benefits observed during standard cycles of 8-12 weeks, often paired with Ipamorelin.
The 'no DAC' version is preferred over CJC-1295 DAC because it preserves natural pulsatile GH release rather than creating a sustained elevation that can desensitize receptors and suppress feedback loops. This distinctive profile is a key reason CJC-1295 maintains its popularity despite the growing number of alternatives.
What Are the Common Criticisms?
The most common complaints about CJC-1295: Possible water retention, tingling/numbness in hands (carpal tunnel-like), increased appetite, mild headache, and flushing at injection site. Effects are dose-dependent and typically subside with continued use.
Cost and sourcing quality are also frequent concerns — results vary significantly between vendors, which is why COA testing is essential.
How Does CJC-1295 Compare to Alternatives?
As a Growth Hormone Releasing Hormone (GHRH) analog, CJC-1295 competes with several similar compounds. The 'no DAC' version is preferred over CJC-1295 DAC because it preserves natural pulsatile GH release rather than creating a sustained elevation that can desensitize receptors and suppress feedback loops.
The gold standard stack is CJC-1295 + Ipamorelin — GHRH + GHRP together produce GH pulses far greater than either alone, through synergistic pituitary stimulation via two distinct receptor pathways.
Bottom Line: Is CJC-1295 Worth It?
Based on the available research and community reports, CJC-1295 is considered promising for increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects. The key factors for success: consistent dosing (100-300 mcg 1-3 times daily, typically before bed), quality sourcing, and realistic expectations over 8-12 weeks, often paired with Ipamorelin cycles.
Complete Guide
CJC-1295 : Benefits, Dosage, Side Effects & Research
Related Reading
- CJC-1295 Dosage Guide
- CJC-1295 Benefits
- CJC-1295 Side Effects
- CJC-1295 Stacking Guide
- CJC-1295 Cycle Guide
- CJC-1295 Research
Calculate Your CJC-1295 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for CJC-1295.
Open Calculator →Research-Grade Sourcing
If you're going to research CJC-1295, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is CJC-1295?
CJC-1295 (CJC-1295 (Modified GRF 1-29)) is a Growth Hormone Releasing Hormone (GHRH) analog. Synthetic peptide analog of GHRH (first 29 amino acids) with four amino acid substitutions for enhanced stability. It is researched for increased growth hormone secretion, improved body composition, better sleep quality, enhanced recovery, anti-aging effects.
What is the recommended CJC-1295 dosage?
Common dosages: 100-300 mcg administered 1-3 times daily, typically before bed via subcutaneous injection. Cycle length: 8-12 weeks, often paired with Ipamorelin. Half-life: ~30 minutes (no DAC), ~8 days (with DAC). Use our peptide calculator for exact reconstitution math.
What are the side effects of CJC-1295?
Possible water retention, tingling/numbness in hands (carpal tunnel-like), increased appetite, mild headache, and flushing at injection site. Effects are dose-dependent and typically subside with continued use.
Is CJC-1295 safe?
CJC-1295 has shown a preliminary safety profile in research. Not FDA-approved. Research chemical status. Banned by WADA. All research should follow appropriate safety protocols.